CytoReason
Michael Vincent has extensive experience in the pharmaceutical industry, serving in various senior leadership roles at Pfizer since June 2011, including Senior Vice President (SVP) of the Inflammation & Immunology Research Unit and SVP of Pharmatherapeutics Clinical Research & Development. Prior to joining Pfizer, Michael Vincent worked at Amgen Inc. from June 2003 to July 2011, where the position held was Medical Sciences Executive Director. Michael Vincent holds an MD PhD from Indiana University Bloomington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
CytoReason
5 followers
CytoReason turns human clinical data into clear biology, to deliver data-driven target discovery and drug development. CytoReason’s access to unmatched proprietary and public data, combined with cutting-edge machine learning technologies, creates our unique biological models of disease, tissue and drug.